Latest news
Loading news…
Vertex Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Boston, Massachusetts, United States Founded 1989 5001-10000 employees For Profit
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Vertex Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$5.15B
Funding Rounds
8
Last Funding
Acquisitions
9
Investments
7
2 exits
Monthly Visits
Contacts
5,257
Ticker
VRTX
NASDAQ
Patents
1,099
188 trademarks
About Vertex Pharmaceuticals
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- VRTX
- Exchange
- NASDAQ
- IPO date
- Jul 25, 1991
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 73
- Mobile apps
- 9
- Downloads (30d)
- 124
- Active products
- 27
- Patents granted
- 1,099
- Trademarks
- 188
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $260.44M
Investor Activity
- Investments
- 7
- Lead investments
- 2
- Portfolio orgs
- 5
- Diversity investments
- 1
- Exits
- 2
- Exits via IPO
- 2
Company Info
- Founded
- 1989
- Employees
- 5001-10000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 3
- Sub-organizations
- 1
- News articles
- 1,739
- Events
- 2
- HQ
- Boston, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Jul 25, 1991
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- 0.6
- Trend (30d)
- 9
- Trend (90d)
- 8.8
- Last leadership hire
- Feb 1, 2026
- Last layoff mention
- Feb 5, 2026
Vertex Pharmaceuticals Funding Rounds
8 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 8Show
Page 1 / 2
Vertex Pharmaceuticals Investments
Loading columns…
0 of 0Show
Page 1 / 1
Vertex Pharmaceuticals Acquisitions
9 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals | $10B | 2026-07-06 | Vertex Pharmaceuticals | BiotechnologyHealth CarePharmaceuticalTherapeutics | United States |
| Alpine Immune Sciences | $4.9B | 2024-04-10 | Vertex Pharmaceuticals | BiotechnologyHealth CareMedical | United States |
| Septerna | — | 2023-09-12 | Vertex Pharmaceuticals | BiotechnologyInformation TechnologyMedicalSoftware | United States |
| ViaCyte | $320M | 2022-07-11 | Vertex Pharmaceuticals | BiotechnologyDiabetesHealth CareMedicalTherapeutics | United States |
| Vectrus | $2.1B | 2022-03-07 | Vertex Pharmaceuticals | Information Technology | United States |
1–5 of 9Show
Page 1 / 2
Vertex Pharmaceuticals Key People
Executive Chairman
President and Chief Executive Officer
Senior Vice President, Genetic Therapies Research
Executive Vice President, Global Research and Chief Scientific Officer
Senior Vice President and Chief Communications Officer
Executive Vice President, Chief of Cell and Genetic Therapies and VCGT Site Head
Disease Area Executive, Type 1 diabetes
Chairman of the Board of Director
Principal Scientist, Translational Engineering
Senior Director
Senior Vice President, International Commercial Operations
Producer
Sr.Director Quality Analytics
Research Scholar
Associate Director, Validation for Continuous Manufacturing and Automation
Sr Director, Global Digital Marketing
Chief Legal Officer
Senior Vice President & Chief Human Resources Officer
VP Research Technology
Director Computational Drug Design
Vice President, Talent and Inclusion, Diversity & Equity
Executive Vice President, Chief Patient Officer. and Chief of Staff
Executive Director, Head of Corporate Responsibility
Senior Principal Data Scientist
5,257
professional contacts at Vertex Pharmaceuticals
Contact execs at Vertex Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Vertex Pharmaceuticals
Loading news…
FAQs about Vertex Pharmaceuticals
People who checked this page also checked these
Sectors Vertex Pharmaceuticals invests & acquires in
Browse the full Acquirezy directory.